Engineering and Development

Management and Executive

Legal and Compliance

Customer Service and Support

Accounting and Finance

Founder, Chief Executive Officer and President

Chief Financial Officer and Executive Vice President, Corporate Strategy

Ultragenyx reports inducement grant under Nasdaq

Lysosomal Storage Disorders (LSDs) Market Set to Soar: Key Players Drive Innovative Treatments in 2025-2033

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

Transcript : Ultragenyx Pharmaceutical Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 10

Senior Vice President, Biostatistics and Statistical Programming

Ultragenyx is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases. The Senior Vice President, Biostatistics and Statistical Programming will lead the statistical aspects of clinical trials and oversee the Biostatistics/Epidemiology and Statistical Programming teams, ensuring the integrity of clinical studies and providing strategic leadership.

Sign up with Google

Sign in with Google